Biosynthesis reveals strong antibacterial and antiviral activity in silver chloride nanoparticles, highlighting new biomedical applications.
In this work, Euphorbia sanctae-catharinae leaf extract is used for the first time to biosynthesize silver chloride nanoparticles (AgCl-NPs) via a green synthesis approach. The formation and properties of the AgCl-NPs were confirmed using various characterization techniques: UV–Vis spectroscopy showed a characteristic absorption peak at 430 nm, indicating nanoparticle formation; X-ray diffraction (XRD) analysis revealed a crystallite size of approximately 24 nm; transmission electron microscopy (TEM) showed predominantly spherical nanoparticles with sizes ranging from 20 to 50 nm; and Fourier-transform infrared spectroscopy (FTIR) identified functional groups from the plant extract involved in nanoparticle stabilization. The MIC values were 62.5 µg/mL for ( S. aureus , E. coli , E. faecalis , S. faecalis , E. aerogenes) , 250 µg/mL for ( S. epidermidis , K. pneumoniae , R. ornithinolytica) , and 125 µg/mL for P. aeruginosa. The MBC values were 500 µg/mL for ( R. ornithinolytica , S. faecalis , K. pneumoniae , S. epidermidis) , and 250 µg/mL for (S. aureus , E. coli , E. faecalis) , and 125 µg/mL for E. aerogenes. Tetracycline’s synergistic actions increased antibacterial effectiveness by 21.4–47%. Furthermore, at a non-toxic dose (MNTC: 31.25 µg/mL), AgCl-NPs showed strong antiviral activity against HSV-1, preventing viral multiplication by 74%. These results demonstrate the potential of AgCl-NPs produced from Euphorbia sanctae-catharinae as a sustainable substitute for fighting viral infections and antibiotic resistance.
No takes yet. Share an insight, caveat, or question.
Eltayeb et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: